PANoptosis - Inflammatory Cell Death
Programmed cell death plays a crucial role in development and host defense with an overlap and crosstalk between pyroptosis, apoptosis and necroptosis in the same cell population, leading to the concept of total cell death called PANoptosis. During PANoptosis activated by bacterial and viral triggers, inflammatory cell death occurs through the collective activation of pyroptosis, apoptosis and necroptosis, which can circumvent pathogen-mediated inhibition of individual death pathways. Molecules from the pyroptotic, apoptotic and necroptotic cell death pathways interact to form a single molecular complex termed the PANoptosome.
Recent studies by the lab of Prof. Kanneganti (St. Jude Children's Research Hospital, Memphis) identified the PANoptosome, a molecular platform triggering inflammatory cell death. PANoptotic stimuli (bacteria or virus) induce the formation of a PANoptosome complex with a number of pyroptotic, apoptotic and necroptotic molecules such as ZBP1, RIPK1, RIPK3, Caspase-1, Caspase-8, NLRP3, Asc and FADD under regulation of ZBP1, TAK1 and Caspase-6.
- Identification of the PANoptosome: A Molecular Platform Triggering Pyroptosis, Apoptosis, and Necroptosis (PANoptosis): S. Christgen, et al.; Front. Cell.Infect. Microbiol. 10, 237 (2020)
Most Trusted, Validated & Cited Antibodies for PANoptosis Research
AdipoGen Life Sciences is a leader in Inflammasome Research and provides the best and thoroughly validated and published antibodies for Apoptosis, Pyroptosis and Necroptosis Research.
|Product Name||PID||Product Description|
|anti-ZBP1, mAb (Zippy-1)||AG-20B-0010||
Recognizes human and mouse ZBP1.
|anti-Asc, pAb (AL177)||AG-25B-0006||
Recognizes human and mouse Asc.
|anti-Caspase-1 (p20) (mouse), mAb (Casper-1)||AG-20B-0042||
Recognizes endogenous full-length and activated (p20 fragment) mouse caspase-1.
|anti-Caspase-1 (p10) (mouse), mAb (Casper-2)||AG-20B-0044||
Recognizes endogenous full-length and activated (p10 fragment) mouse caspase-1.
|anti-Caspase-1 (p20) (human), mAb (Bally-1)||AG-20B-0048||
Recognizes endogenous full-length and activated (p20 fragment) human caspase-1.
|anti-Caspase-4 /11 (p20), mAb (Flamy-1)||AG-20B-0060||
Recognizes endogenous full-length protein and activated (p20) fragment of mouse and human caspase-4/11. Does not detect human Caspase-5.
|anti-Caspase-8 (human), mAb (C15)||AG-20B-0057||Recognizes the p18 subunit of human caspase-8.|
|anti-Caspase-8 (mouse), mAb (1G12)||AG-20T-0137||Recognizes full-length and the p18 cleaved fragment of mouse caspase-8.|
|anti-Caspase-8 (mouse), mAb (3B10)||AG-20T-0138||Recognizes full-length and the p18 cleaved fragment of mouse caspase-8.|
|anti-FLIP, mAb (Dave-2)||AG-20B-0005||Recognizes an epitope (aa 1-200) present in both short (FLIPS) and long (FLIPL) splice variants of human and mouse FLIP.|
|anti-FLIP (human), mAb (NF6)||AG-20B-0056||Recognizes short (FLIPS) and long (FLIPL) splice variants of human FLIP. This antibody recognizes an epitope in the N-terminal DED region (aa1-194).|
|NEW anti-FADD (human), mAb (1C4)||AG-20B-0080||Recognizes the C-terminus of human FADD only in its unphosphorylated form.|
|NEW anti-FADD (human), mAb (1C4) (Biotin)||AG-20B-0080B||Recognizes the C-terminus of human FADD only in its unphosphorylated form.|
|anti-NLRP3/NALP3, mAb (Cryo-2)||AG-20B-0014||
Recognizes mouse and human NLRP3/NALP3.
Over 1000 Citations!
Visit also our Inflammasome Landing Page
Visit also our Pyroptosis Landing Page